Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Colitis Gravis

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Colitis Gravis in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Q1
Duan, X1
Fan, H1
Xu, M1
Tang, Q1
Zhang, L1
Shou, Z1
Liu, X1
Zuo, D1
Yang, J1
Deng, S1
Dong, Y1
Wu, H1
Liu, Y1
Nan, Z1
Jiang, W1
Han, YP1
Hu, M1
Bao, XQ1
Yan, Y1
Chen, G1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Colitis Gravis

ArticleYear
Oxymatrine protects against DSS-induced colitis via inhibiting the PI3K/AKT signaling pathway.
    International immunopharmacology, 2017, Volume: 53

    Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Cell Differentiation; Cells, Cultured; Chromones; Coli

2017
A study on regulatory mechanism of miR-223 in ulcerative colitis through PI3K/Akt-mTOR signaling pathway.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:11

    Topics: Animals; Apoptosis; Chromones; Colitis, Ulcerative; Dextran Sulfate; Dimethylhydrazines; Disease Mod

2019